Maralixibat

ATC A05AX04 · 7 markets · 25 records

Maralixibat 7 markets · 25 records Forms

US 6 records · 6 strengths

30 mgtabletLivmarli also in CA·GB
20 mgtabletLivmarli also in CA·GB
15 mgtabletLivmarli also in CA·GB
10 mgtabletLivmarli also in CA·GB
9.5 mgliquidLivmarli also in CA·GB
19 mgliquidLivmarli also in CA

CA 6 records · 6 strengths

30 mgtabletLivmarli also in US·GB
20 mgtabletLivmarli also in US·GB
15 mgtabletLivmarli also in US·GB
10 mgtabletLivmarli also in US·GB
9.5 mgliquidLivmarli also in US·GB
19 mgliquidLivmarli also in US

GB 5 records · 5 strengths

30 mgtabletLivmarli also in US·CA
20 mgtabletLivmarli also in US·CA
15 mgtabletLivmarli also in US·CA
10 mgtabletLivmarli also in US·CA
9.5 mgliquidLivmarli 9.5mg/ml oral solution also in US·CA

ES 1 records · 1 strengths

9.5 mg/1 mLliquidLivmarli

TW 1 records · 1 strengths

Records without a stated strength · 1 Livmarli、邁芮倍口服溶液

HK 1 records · 1 strengths

Records without a stated strength · 1 Livmarli 9.5mg/ml oral solution

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Livmarli

Side-by-side table

Strength / form / release	US	GB	CA	ES	TW	HK	EU
30 mg tablet	Livmarli	Livmarli	Livmarli	not recorded	not recorded	not recorded	not recorded
20 mg tablet	Livmarli	Livmarli	Livmarli	not recorded	not recorded	not recorded	not recorded
15 mg tablet	Livmarli	Livmarli	Livmarli	not recorded	not recorded	not recorded	not recorded
10 mg tablet	Livmarli	Livmarli	Livmarli	not recorded	not recorded	not recorded	not recorded
9.5 mg liquid	Livmarli	Livmarli 9.5mg/ml oral solution	Livmarli	not recorded	not recorded	not recorded	not recorded
19 mg liquid	Livmarli	not recorded	Livmarli	not recorded	not recorded	not recorded	not recorded
9.5 mg/1 mL liquid	not recorded	not recorded	not recorded	Livmarli	not recorded	not recorded	not recorded
not disclosed liquid	not recorded	not recorded	not recorded	not recorded	Livmarli 邁芮倍口服溶液	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	not recorded	not recorded	Livmarli 9.5mg/ml oral solution	Livmarli

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

3 more strength/form rows are recorded only in ES · TW · HK · EU and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en ES · TW · HK · EU que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 ES · TW · HK · EU 有记录（未在本表显示）。另有 3 個規格/劑型僅在 ES · TW · HK · EU 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.